Combination Pricing

Combination therapies will fundamentally change the paradigm for drug commercialization. Companies will need to take a more sophisticated approach to their pricing and reimbursement strategies… capable of factoring in the impact of a significant number of variables including major unknowns… The stakes and cost of getting it wrong are rising.
— David Greber and Srikant Vaidyanathan, Challenge of Pricing Combination Therapies, 
 BCG Perspectives, 2014

Pharma is in need of a new pricing model combining assessment of value with market dynamics.

In our marketplace, we offer pharmaceutical companies and payers a platform to effectively negotiate pricing for combination therapies.